Axis-Shield Ltd Aktie

Aktien

893587

GB0008039975

ASD

Medizinische Versorgung

Verzögert London S.E. Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^GBX	-.--%		-.--%	-.--%

Chart Axis-Shield Ltd

Dauer

Zeitraum

Stil

Dynamischer Chart

Nachrichten in anderen Sprachen zu Axis-Shield Ltd

Axis Shield : The Effect of Food Intake on the Pharmacokinetics of Vadadustat Following Single Dose Administration	29.07.20
Axis Shield : Randomized, Double-Blinded, Active-Controlled (Darbepoetin Alfa), Phase 3 Study of Vadadustat in Chronic Kidney Disease Patients With Anemia on Hemodialysis in Japan	29.07.20
Axis Shield : Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia	29.07.20
Axis Shield : Targeted Literature Review of Patient-reported Burden of Anemia in Chronic Kidney Disease	29.07.20
Efficacy and Safety of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Being Evaluated for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Japanese Subjects: Results from Phase 2 Studies (encore)	29.07.20

Mehr Börsen-Nachrichten

Unternehmensprofil

Axis-Shield Ltd ist ein in Großbritannien ansässiges Unternehmen. Das Unternehmen entwickelt, produziert und vermarktet in-vitro-diagnostische Produkte.

Sektor

Medizinische Versorgung

Mehr Unternehmensinformationen

Sektor Diagnostische & Testsubstanzen

	% 1. Jan.	Kap.
AXIS-SHIELD LTD	-.--%	0
BIOMÉRIEUX	-1.29%	12.64 Mrd.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.47%	8.46 Mrd.
LANTHEUS HOLDINGS, INC.	+22.61%	5.27 Mrd.
AUTOBIO DIAGNOSTICS CO., LTD.	-2.03%	4.49 Mrd.
10X GENOMICS, INC.	-53.56%	3.11 Mrd.
ANDON HEALTH CO., LTD.	+19.30%	2.87 Mrd.
MYRIAD GENETICS, INC.	+33.07%	2.31 Mrd.
VITROLIFE AB	-8.42%	2.23 Mrd.
GUANGZHOU WONDFO BIOTECH CO.,LTD	-3.55%	1.89 Mrd.

Diagnostische & Testsubstanzen